Beta Synapset petites capsules
Natural health product licensed in Canada
- Licence holder
- Bioflash inc
- NPN or DIN-HM
- 80107749
- Status
- Active licence
- Licence date
- 1 February 2021
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Malate de magnésium | 18.8 mg | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 7.5 mg | Not calculated |
| Zinc Source : Citrate de zinc dihydraté | 0.9 mg | Not calculated |
| Cuivre Source : Diglycinate de cuivre (II) | 25 microgram | Not calculated |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 27 mg Acide docosahexaénoïque | 225 mg | Not calculated |
Non-medicinal ingredients
Phosphate dicalcique, Gélatine, Sorbate de potassium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 14 years ; maximum: 18 years | 4 Capsule | 2 Tous les jours |
| Adolescentes | minimum: 9 years ; maximum: 13 years | 2 Capsule | 2 Tous les jours |
| Adultes | minimum: 19 years | 4 Capsule | 2 Tous les jours |
| Enfants | minimum: 5 years ; maximum: 9 years | 2 Capsule | 2 days |
Uses authorised in Canada
Aide à prévenir les déficiences alimentaires observées chez les individus souffrant de TDA/TDAH: magnésium, zinc, vitamine B6 et acides gras (AEP,ADH). Aide à contribuer à la santé cognitive et/ou aux fonctions cérébrales. Des études cliniques ont montré que chez les enfants souffrant de TDAH certains acides gras sont déficients et qu'un apport de certains Omega-3 dont AEPexerçait une influence bénéfique sur leur comportement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80107749
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.